Biomedical Engineering Reference
In-Depth Information
delivery of allogenic muscle stem cells induces long-term muscle repair and clinical efficacy
in duchenne muscular dystrophy dogs. Am J Pathol 179(5):2501-2518
56. Zheng B, Cao B, Crisan M, Sun B, Li G, Logar A, Yap S, Pollett JB, Drowley L, Cassino T,
Gharaibeh B, Deasy BM, Huard J, Peault B (2007) Prospective identification of myogenic
endothelial cells in human skeletal muscle. Nat Biotechnol 25(9):1025-1034
57. Inoue H, Yamanaka S (2011) The use of induced pluripotent stem cells in drug development.
Clin Pharmacol Ther 89(5):655-661
58. Tan KY, Eminli S, Hettmer S, Hochedlinger K, Wagers AJ (2011) Efficient generation of iPS
cells from skeletal muscle stem cells. PLoS One 6(10):e26406
59. Darabi R, Baik J, Clee M, Kyba M, Tupler R, Perlingeiro RC (2009) Engraftment of
embryonic stem
cell-derived myogenic
progenitors in a dominant
model of muscular
dystrophy. Exp Neurol 220(1):212-216
60. Koenig M, Hoffman EP, Bertelson CJ, Monaco AP, Feener C, Kunkel LM (1987) Complete
cloning of the duchenne muscular dystrophy (DMD) cDNA and preliminary genomic
organization of the DMD gene in normal and affected individuals. Cell 50(3):509-517
61. Miyagoe-Suzuki Y, Takeda S (2010) Gene therapy for muscle disease. Exp Cell Res
316(18):3087-3092
62. Tang Y, Cummins J, Huard J, Wang B (2010) AAV-directed muscular dystrophy gene
therapy. Expert Opin Biol Ther 10(3):395-408
63. Wang B, Li J, Xiao X (2000) Adeno-associated virus vector carrying human minidystrophin
genes effectively ameliorates muscular dystrophy in mdx mouse model. Proc Natl Acad Sci
USA 97(25):13714-13719
64. Tang Y, Reay DP, Salay MN, Mi MY, Clemens PR, Guttridge DC, Robbins PD, Huard J,
Wang B (2010) Inhibition of the IKK/NF-kappaB pathway by AAV gene transfer improves
muscle regeneration in older mdx mice. Gene Ther 17(12):1476-1483
65. Sun JY, Anand-Jawa V, Chatterjee S, Wong KK (2003) Immune responses to adeno-
associated virus and its recombinant vectors. Gene Ther 10(11):964-976
66. Mendell
JR,
Clark
KR
(2006)
Challenges
for
gene
therapy
for
muscular
dystrophy.
Curr Neurol Neurosci Rep 6(1):47-56
67. Gilbert PM, Havenstrite KL, Magnusson KE, Sacco A, Leonardi NA, Kraft P, Nguyen NK,
Thrun S, Lutolf MP, Blau HM (2010) Substrate elasticity regulates skeletal muscle stem cell
self-renewal in culture. Science 329(5995):1078-1081
68. Carnio S, Serena E, Rossi CA, De Coppi P, Elvassore N, Vitiello L (2011) Three-dimensional
porous scaffold allows long-term wild-type cell delivery in dystrophic muscle. J Tissue Eng
Regen Med 5(1):1-10
69. Jang JH, Schaffer DV, Shea LD (2011) Engineering biomaterial systems to enhance viral
vector gene delivery. Mol Ther 19(8):1407-1415
70. Falco EE, Wang MO, Thompson JA, Chetta JM, Yoon DM, Li EZ, Kulkami MM, Shah S,
Pandit A, Roth JS, Fisher JP (2011) Porous EH and EH-PEG scaffolds as gene delivery
vehicles to skeletal muscle. Pharm Res 28(6):1306-1316
71. Osada K, Shiotani T, Tockary TA, Kobayashi D, Oshima H, Ikeda S, Christie RJ, Itaka K,
Kataoka K (2012) Enhanced gene expression promoted by the quantized folding of pDNA
within polyplex micelles. Biomaterials 33(1):325-332
72. Fisher KD, Stallwood Y, Green NK, Ulbrich K, Mautner V, Seymour LW (2001) Polymer-
coated adenovirus permits efficient retargeting and evades neutralising antibodies. Gene Ther
8(5):341-348
73. Subramanian IV, Fernandes BC, Robinson T, Koening J, Lapara KS, Ramakrishnan S (2009)
AAV-2-mediated expression of IGF-1 in skeletal myoblasts stimulates angiogenesis and cell
survival. J Cardiovasc Transl Res 2(1):81-92
74. Galvez BG, Sampaolesi M, Brunelli S, Covarello D, Gavina M, Rossi B, Constantin G,
Torrente
Y,
Cossu
G
(2006)
Complete
repair
of
dystrophic
skeletal
muscle
by
mesoangioblasts with enhanced migration ability. J Cell Biol 174(2):231-243
